Rule: 2-40.008 Prev Up Next
| Rule Title: Rescheduling of Drug Product Under Section 893.0355 | |||
| Department: | DEPARTMENT OF LEGAL AFFAIRS |
![]() Add to MyFLRules Favorites |
|
| Division: | Departmental | ||
| Chapter: | SCHEDULING AND RESCHEDULING OF CONTROLLED SUBSTANCES | ||
Latest version of the final adopted rule presented in Florida Administrative Code (FAC):
|
Effective Date: | 11/23/2025 |
| History Notes: | Rulemaking Authority 893.0355 FS. Law Implemented 893.0355 FS. History–New 11-23-25. | |
| References in this version: | No reference(s). |
| Notice / Adopted |
Description | ID | Publish Date |
|
|---|---|---|---|---|
|
Rescheduling of Drug Product Under Section 893.0355 | 30189036 |
Effective: 11/23/2025 |
|
|
The proposed rule is intended to reschedule Xylazine, a drug product approved by the U.S. Food and Drug Administration (FDA) as an Animal Drug Product, from Schedule I to a Schedule I with exception for Veterinary use. | 29981456 |
9/12/2025 Vol. 51/178 |
|
|
The proposed rule development is intended to reschedule Xylazine, a drug product approved by the U.S. Food and Drug Administration (FDA) as an Animal Drug Product, from a Schedule I to a Schedule I with exception for Veterinary .... | 29929464 |
8/28/2025 Vol. 51/168 |
|


